🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Circulating Tumor DNA

cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas NCT07178847NA4 sites📍 Aurillac📍 Clermont-Ferrand📍 Lyon Centre Jean Perrin · Tests: blood sampling ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer" NCT07381764Phase 226 sites📍 Alessandria📍 Ancona📍 Aviano Gruppo Oncologico Italia Meridionale · Tests: Erbitux (Cetuximab), Bevacizumab, Irinotecan, Trifluridine/tipiracil Prospective ctDNA Testing in Large B-Cell Lymphoma NCT07878351n/a2 sites📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Standard-of-care first-line immunochemotherapy containing an anti-CD20 monoclonal antibody and an anthracycline, such a… ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness NCT07084558NA14 sites📍 Vienna📍 Baden📍 Dornbirn Austrian Breast & Colorectal Cancer Study Group · Tests: blood sample for Signatera (TM) test, biopsy for Ki-67 assessment, FFPE tumor sample for Signatera (TM) test (archived) The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer NCT05502523NA4 sites📍 Abington📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Pulmonary Artery-First Surgical Technique, Biospecimen Collection Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases NCT04491929n/a1 site📍 Aarhus N Aarhus University Hospital Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) NCT04434040Phase 27 sites📍 San Francisco📍 Chicago📍 New Lenox Dana-Farber Cancer Institute · Tests: Atezolizumab, Sacituzumab govitecan Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial NCT06434896NA29 sites📍 's-Hertogenbosch📍 Alkmaar📍 Almelo UMC Utrecht · Tests: ctDNA analysis after surgery Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis NCT07030283Phase 11 site📍 Aurora University of Colorado, Denver · Tests: Paclitaxel, NALIRIFOX A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC NCT07058519Phase 21 site📍 Shanghai Shanghai Chest Hospital · Tests: Osimertinib-based adaptive treatment, Osimertinib 80 MG ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer NCT06589388n/a1 site📍 Ho Chi Minh City Gene Solutions Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer NCT06706557n/a1 site📍 Milan European Institute of Oncology Detection of the BRAF V600E Mutation in Liquid Biopsy Using the CRISPR/Cas12a System NCT07870265NA1 site📍 Brno Masaryk Memorial Cancer Institute · Tests: Novel CRISPR/Cas12a Electrochemical Bioassay, Reference Standard Molecular Diagnostics (NGS and ddPCR), Serial Peripher… EUS Guided HVA and PVA for Circulating Tumor DNA in Patients NCT04782557NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: EUS-guided portal vein and hepatic vein aspiration A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer NCT04985266Phase 249 sites📍 Angers📍 Annecy📍 Avignon Royal Marsden NHS Foundation Trust · Tests: Palbociclib 125Mg Tab, Fulvestrant injection, Tamoxifen, Letrozole, Exemestane PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC NCT06977074Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: PD-1 inhibitor, Platinum Doublet Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401) NCT06561178n/a1 site📍 Guangzhou Sun Yat-Sen University Cancer Center · Tests: molecular residual disease detection Detection of Minimal Residual Disease Post-prostatectomy NCT07334275n/a1 site📍 Nijmegen Radboud University Medical Center Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer NCT04530890NA1 site📍 Poitiers Poitiers University Hospital · Tests: Blood samples Rarecells Molecular Biomarkers for Early Detection of Lung Cancer NCT06546007n/a1 site📍 Roma Rarecells Diagnostics SAS · Tests: CTC-DNA NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer NCT05572801NA13 sites📍 Herlev📍 Vejle📍 Aarhus Aarhus University Hospital · Tests: AMR B: HPV positive ctDNA guided imaging in follow-up The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study NCT04957901n/a1 site📍 Guangzhou Sun Yat-sen University · Tests: Pediatric lymphoma protocol Circulating Tumor DNA in High Risk Localized Prostate Cancer NCT07222436n/a1 site📍 Pittsburgh University of Pittsburgh RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based NCT06614647NA9 sites📍 Herning📍 Randers📍 Aalborg University of Aarhus · Tests: Recurrence monitoring with circulating tumor DNA (ctDNA) as a high risk biomarker, Monitoring for late adverse effects … Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer NCT05889247NA5 sites📍 Hillerød📍 Næstved📍 Roskilde Zealand University Hospital · Tests: Circulating tumor DNA treatment monitoring ctDNA in Cutaneous Squamous Cell Carcinoma NCT06875609n/a1 site📍 Boston Massachusetts Eye and Ear Infirmary · Tests: Blood and Tissue Collection Tirzepatide Weight Loss for MRD+ Early Breast Cancer NCT06517212Phase 21 site📍 Dallas Baylor Research Institute · Tests: Tirzepatide Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL) NCT06088381Phase 25 sites📍 Baltimore📍 Baltimore📍 Bel Air University of Maryland, Baltimore · Tests: Experimental Observation, Observation per Standard of Care, Adjuvant Treatment per Standard of Care, Circulating Tumor … Early Detection and Post-operative Monitoring of Gastric Cancer NCT06232395n/a2 sites📍 Shanghai📍 Shanghai Suzhou Huhu Health & Technology Inc. · Tests: DNA test Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA NCT05334277Phase 226 sites📍 Changchun📍 Chengdu📍 Dongguan Sun Yat-sen University · Tests: Furmonertinib, Furmonertinib, Furmonertinib/Pemetrexed/Carboplatin, Furmonertinib/Pemetrexed/Carboplatin/Bevacizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy